Stxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation

REFERENCES

• Barbieri, C. E., C. E. Barton, and J. A. Pietenpol. 2003. ΔNp63α expression is regulated by the phosphoinositide 3-kinase pathway. J. Biol. Chem. 278:51408–51414.
   PubMed Web of Science ®Google Scholar
• Barbieri, C. E., C. A. Perez, K. N. Johnson, K. A. Ely, D. Billheimer, and J. A. Pietenpol. 2005. IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium. Cancer Res. 65:2314–2320.
   PubMedGoogle Scholar
• Blanpain, C., and E. Fuchs. 2007. p63: revving up epithelial stem-cell potential. Nat. Cell Biol. 9:731–733.
   PubMedGoogle Scholar
• Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761–771.
   PubMed Web of Science ®Google Scholar
• Candi, E., A. Rufini, A. Terrinoni, D. Dinsdale, M. Ranalli, A. Paradisi, V. De Laurenzi, L. G. Spagnoli, M. V. Catani, S. Ramadan, R. A. Knight, and G. Melino. 2006. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 13:1037–1047.
   PubMedGoogle Scholar
• Carroll, D. K., J. S. Carroll, C. O. Leong, F. Cheng, M. Brown, A. A. Mills, J. S. Brugge, and L. W. Ellisen. 2006. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell Biol. 8:551–561.
   PubMed Web of Science ®Google Scholar
• Chan, W. M., W. Y. Siu, A. Lau, and R. Y. Poon. 2004. How many mutant p53 molecules are needed to inactivate a tetramer? Mol. Cell. Biol. 24:3536–3551.
   PubMed Web of Science ®Google Scholar
• Chang, E. C., M. Barr, Y. Wang, V. Jung, H. P. Xu, and M. H. Wigler. 1994. Cooperative interaction of S. pombe proteins required for mating and morphogenesis. Cell 79:131–141.
   PubMed Web of Science ®Google Scholar
• Danovi, S. A., M. Rossi, K. Gudmundsdottir, M. Yuan, G. Melino, and S. Basu. 2007. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ. 15:1752–1579.
   Google Scholar
• Davison, T. S., C. Vagner, M. Kaghad, A. Ayed, D. Caput, and C. H. Arrowsmith. 1999. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274:18709–18714.
   PubMed Web of Science ®Google Scholar
• Deyoung, M. P., C. M. Johannessen, C. O. Leong, W. Faquin, J. W. Rocco, and L. W. Ellisen. 2006. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res. 66:9362–9368.
   PubMedGoogle Scholar
• Dohn, M., S. Zhang, and X. Chen. 2001. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193–3205.
   PubMed Web of Science ®Google Scholar
• Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
   PubMed Web of Science ®Google Scholar
• Flores, E. R., S. Sengupta, J. B. Miller, J. J. Newman, R. Bronson, D. Crowley, A. Yang, F. McKeon, and T. Jacks. 2005. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363–373.
   PubMed Web of Science ®Google Scholar
• Fomenkov, A., R. Zangen, Y. P. Huang, M. Osada, Z. Guo, T. Fomenkov, B. Trink, D. Sidransky, and E. A. Ratovitski. 2004. RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 3:1285–1295.
   PubMed Web of Science ®Google Scholar
• Ghioni, P., F. Bolognese, P. H. Duijf, H. Van Bokhoven, R. Mantovani, and L. Guerrini. 2002. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol. 22:8659–8668.
   PubMed Web of Science ®Google Scholar
• Gressner, O., T. Schilling, K. Lorenz, E. Schulze Schleithoff, A. Koch, H. Schulze-Bergkamen, A. Maria Lena, E. Candi, A. Terrinoni, M. Valeria Catani, M. Oren, G. Melino, P. H. Krammer, W. Stremmel, and M. Muller. 2005. TAp63α induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 24:2458–2471.
   PubMed Web of Science ®Google Scholar
• Helton, E. S., J. Zhu, and X. Chen. 2006. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J. Biol. Chem. 281:2533–2542.
   PubMedGoogle Scholar
• Hibi, K., B. Trink, M. Patturajan, W. H. Westra, O. L. Caballero, D. E. Hill, E. A. Ratovitski, J. Jen, and D. Sidransky. 2000. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 97:5462–5467.
   PubMed Web of Science ®Google Scholar
• Huang, Y. P., G. Wu, Z. Guo, M. Osada, T. Fomenkov, H. L. Park, B. Trink, D. Sidransky, A. Fomenkov, and E. A. Ratovitski. 2004. Altered sumoylation of p63α contributes to the split-hand/foot malformation phenotype. Cell Cycle 3:1587–1596.
   PubMed Web of Science ®Google Scholar
• Ingham, R. J., K. Colwill, C. Howard, S. Dettwiler, C. S. Lim, J. Yu, K. Hersi, J. Raaijmakers, G. Gish, G. Mbamalu, L. Taylor, B. Yeung, G. Vassilovski, M. Amin, F. Chen, L. Matskova, G. Winberg, I. Ernberg, R. Linding, P. O'Donnell, A. Starostine, W. Keller, P. Metalnikov, C. Stark, and T. Pawson. 2005. WW domains provide a platform for the assembly of multiprotein networks. Mol. Cell. Biol. 25:7092–7106.
   PubMedGoogle Scholar
• Jacobs, W. B., G. Govoni, D. Ho, J. K. Atwal, F. Barnabe-Heider, W. M. Keyes, A. A. Mills, F. D. Miller, and D. R. Kaplan. 2005. p63 is an essential proapoptotic protein during neural development. Neuron 48:743–756.
   PubMed Web of Science ®Google Scholar
• Keyes, W. M., H. Vogel, M. I. Koster, X. Guo, Y. Qi, K. M. Petherbridge, D. R. Roop, A. Bradley, and A. A. Mills. 2006. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc. Natl. Acad. Sci. USA 103:8435–8440.
   PubMed Web of Science ®Google Scholar
• Keyes, W. M., Y. Wu, H. Vogel, X. Guo, S. W. Lowe, and A. A. Mills. 2005. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 19:1986–1999.
   PubMed Web of Science ®Google Scholar
• Kraft, C., H. C. Vodermaier, S. Maurer-Stroh, F. Eisenhaber, and J. M. Peters. 2005. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol. Cell 18:543–553.
   PubMed Web of Science ®Google Scholar
• Kraus, S., D. Gioeli, T. Vomastek, V. Gordon, and M. J. Weber. 2006. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res. 66:11047–11054.
   PubMedGoogle Scholar
• Lee, H. O., J. H. Lee, E. Choi, J. Y. Seol, Y. Yun, and H. Lee. 2006. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner. Biochem. Biophys. Res. Commun. 344:166–172.
   PubMedGoogle Scholar
• Levy, D., Y. Adamovich, N. Reuven, and Y. Shaul. 2007. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 14:743–751.
   PubMedGoogle Scholar
• Li, Y., Z. Zhou, and C. Chen. 2008. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ. 15:1941–1951.
   PubMed Web of Science ®Google Scholar
• Liefer, K. M., M. I. Koster, X. J. Wang, A. Yang, F. McKeon, and D. R. Roop. 2000. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res. 60:4016–4020.
   PubMed Web of Science ®Google Scholar
• Liu, Y. V., J. H. Baek, H. Zhang, R. Diez, R. N. Cole, and G. L. Semenza. 2007. RACK1 competes with HSP90 for binding to HIF-1α and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1α. Mol. Cell 25:207–217.
   PubMed Web of Science ®Google Scholar
• Marchbank, A., L. J. Su, P. Walsh, J. DeGregori, K. Penheiter, T. B. Grayson, R. P. Dellavalle, and L. A. Lee. 2003. The CUSP ΔNp63α isoform of human p63 is downregulated by solar-simulated ultraviolet radiation. J. Dermatol. Sci. 32:71–74.
   PubMedGoogle Scholar
• Matheny, K. E., C. E. Barbieri, J. C. Sniezek, C. L. Arteaga, and J. A. Pietenpol. 2003. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 113:936–939.
   PubMed Web of Science ®Google Scholar
• McCahill, A., J. Warwicker, G. B. Bolger, M. D. Houslay, and S. J. Yarwood. 2002. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 62:1261–1273.
   PubMed Web of Science ®Google Scholar
• McKeon, F. 2004. p63 and the epithelial stem cell: more than status quo? Genes Dev. 18:465–469.
   PubMed Web of Science ®Google Scholar
• Mills, A. A. 2006. p63: oncogene or tumor suppressor? Curr. Opin. Genet. Dev. 16:38–44.
   PubMed Web of Science ®Google Scholar
• Mills, A. A., B. Zheng, X. J. Wang, H. Vogel, D. R. Roop, and A. Bradley. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708–713.
   PubMed Web of Science ®Google Scholar
• Min, J., S. Okada, M. Kanzaki, J. S. Elmendorf, K. J. Coker, B. P. Ceresa, L. J. Syu, Y. Noda, A. R. Saltiel, and J. E. Pessin. 1999. Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes. Mol. Cell 3:751–760.
   PubMedGoogle Scholar
• Nguyen, B. C., K. Lefort, A. Mandinova, D. Antonini, V. Devgan, G. Della Gatta, M. I. Koster, Z. Zhang, J. Wang, A. Tommasi di Vignano, J. Kitajewski, G. Chiorino, D. R. Roop, C. Missero, and G. P. Dotto. 2006. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20:1028–1042.
   PubMed Web of Science ®Google Scholar
• Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4:839–843.
   PubMed Web of Science ®Google Scholar
• Ozaki, T., K. Watanabe, T. Nakagawa, K. Miyazaki, M. Takahashi, and A. Nakagawara. 2003. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Oncogene 22:3231–3242.
   PubMedGoogle Scholar
• Patturajan, M., S. Nomoto, M. Sommer, A. Fomenkov, K. Hibi, R. Zangen, N. Poliak, J. Califano, B. Trink, E. Ratovitski, and D. Sidransky. 2002. ΔNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 1:369–379.
   PubMedGoogle Scholar
• Pellegrini, G., E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza, D. Ponzin, F. McKeon, and M. De Luca. 2001. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98:3156–3161.
   PubMed Web of Science ®Google Scholar
• Perez-Losada, J., D. Wu, R. DelRosario, A. Balmain, and J. H. Mao. 2005. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. Oncogene 24:5521–5524.
   PubMedGoogle Scholar
• Rocco, J. W., C. O. Leong, N. Kuperwasser, M. P. DeYoung, and L. W. Ellisen. 2006. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9:45–56.
   PubMed Web of Science ®Google Scholar
• Rossi, M., R. I. Aqeilan, M. Neale, E. Candi, P. Salomoni, R. A. Knight, C. M. Croce, and G. Melino. 2006. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc. Natl. Acad. Sci. USA 103:12753–12758.
   PubMed Web of Science ®Google Scholar
• Rossi, M., V. De Laurenzi, E. Munarriz, D. R. Green, Y. C. Liu, K. H. Vousden, G. Cesareni, and G. Melino. 2005. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 24:836–848.
   PubMed Web of Science ®Google Scholar
• Rossi, M., M. De Simone, A. Pollice, R. Santoro, G. La Mantia, L. Guerrini, and V. Calabro. 2006. Itch/AIP4 associates with and promotes p63 protein degradation. Cell Cycle 5:1816–1822.
   PubMed Web of Science ®Google Scholar
• Senoo, M., F. Pinto, C. P. Crum, and F. McKeon. 2007. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523–536.
   PubMed Web of Science ®Google Scholar
• Strano, S., E. Munarriz, M. Rossi, L. Castagnoli, Y. Shaul, A. Sacchi, M. Oren, M. Sudol, G. Cesareni, and G. Blandino. 2001. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276:15164–15173.
   PubMed Web of Science ®Google Scholar
• Suh, E. K., A. Yang, A. Kettenbach, C. Bamberger, A. H. Michaelis, Z. Zhu, J. A. Elvin, R. T. Bronson, C. P. Crum, and F. McKeon. 2006. p63 protects the female germ line during meiotic arrest. Nature 444:624–628.
   PubMed Web of Science ®Google Scholar
• Truong, A. B., M. Kretz, T. W. Ridky, R. Kimmel, and P. A. Khavari. 2006. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20:3185–3197.
   PubMed Web of Science ®Google Scholar
• Urist, M., T. Tanaka, M. V. Poyurovsky, and C. Prives. 2004. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18:3041–3054.
   PubMed Web of Science ®Google Scholar
• Urist, M. J., C. J. Di Como, M. L. Lu, E. Charytonowicz, D. Verbel, C. P. Crum, T. A. Ince, F. D. McKeon, and C. Cordon-Cardo. 2002. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161:1199–1206.
   PubMed Web of Science ®Google Scholar
• Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205–214.
   PubMed Web of Science ®Google Scholar
• Westfall, M. D., A. S. Joyner, C. E. Barbieri, M. Livingstone, and J. A. Pietenpol. 2005. Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of ΔNp63α. Cell Cycle 4:710–716.
   PubMed Web of Science ®Google Scholar
• Westfall, M. D., D. J. Mays, J. C. Sniezek, and J. A. Pietenpol. 2003. The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23:2264–2276.
   PubMed Web of Science ®Google Scholar
• Winberg, G., L. Matskova, F. Chen, P. Plant, D. Rotin, G. Gish, R. Ingham, I. Ernberg, and T. Pawson. 2000. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell. Biol. 20:8526–8535.
   PubMed Web of Science ®Google Scholar
• Wu, G., S. Nomoto, M. O. Hoque, T. Dracheva, M. Osada, C. C. Lee, S. M. Dong, Z. Guo, N. Benoit, Y. Cohen, P. Rechthand, J. Califano, C. S. Moon, E. Ratovitski, J. Jen, D. Sidransky, and B. Trink. 2003. ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 63:2351–2357.
   PubMed Web of Science ®Google Scholar
• Wu, G., M. Osada, Z. Guo, A. Fomenkov, S. Begum, M. Zhao, S. Upadhyay, M. Xing, F. Wu, C. Moon, W. H. Westra, W. M. Koch, R. Mantovani, J. A. Califano, E. Ratovitski, D. Sidransky, and B. Trink. 2005. ΔNp63α up-regulates the Hsp70 gene in human cancer. Cancer Res. 65:758–766.
   PubMed Web of Science ®Google Scholar
• Yang, A., M. Kaghad, D. Caput, and F. McKeon. 2002. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18:90–95.
   PubMed Web of Science ®Google Scholar
• Yang, A., M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming, V. Dotsch, N. C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2:305–316.
   PubMed Web of Science ®Google Scholar
• Yang, A., R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R. T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714–718.
   PubMed Web of Science ®Google Scholar
• Yu, H. 2007. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol. Cell 27:3–16.
   PubMed Web of Science ®Google Scholar
• Zupnick, A., and C. Prives. 2006. Mutational analysis of the p53 core domain L1 loop. J. Biol. Chem. 281:20464–20473.
   PubMed Web of Science ®Google Scholar